Business Context and Reporting Period
This Form 8-K Current Report is filed by U.S. Physical Therapy, Inc. (USPH) on August 12, 2026. The filing discloses the appointment of a new Chief Financial Officer and the execution of a material employment agreement effective September 1, 2026.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and personnel changes.
Material Changes
- Executive Appointment: Nchacha Etta was appointed Executive Vice President and Chief Financial Officer, effective September 1, 2026.
- Leadership Transition: Jason Curtis will cease serving as Interim Chief Financial Officer but will continue as Senior Vice President, Finance and Accounting.
- Compensation Structure: Mr. Etta's agreement includes a $625,000 annual base salary, performance-based bonuses, and significant equity grants.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. It details the background of the new CFO, noting his prior roles at Omnicell, EssilorLuxottica, Johnson & Johnson Vision, and The Coca-Cola Company. The agreement includes standard severance, change in control benefits, and non-competition covenants extending up to two years post-termination.
Investor Verification Checklist
- Verify the exact vesting schedule and performance conditions for the $550,000 initial stock grant and the $200,000 prorated grant.
- Review the full text of the Employment Agreement (Exhibit 10.1) for specific severance triggers and change in control definitions.
- Confirm the transition timeline for the CFO role between Jason Curtis and Nchacha Etta.
- Check subsequent filings for any impact of this appointment on the company's internal controls or financial reporting processes.